Efficacy and safety of antibody induction therapy in the current era of kidney transplantation

AbstractBackground. Antibody induction with polyclonal rabbit-antithymocyte globulin (rATG) or an interleukin-2 receptor antagonist (IL−2RA) is widely used in

Saved in:
Bibliographic Details
Main Authors: Opelz, Gerhard (Author) , Unterrainer, Christian (Author) , Süsal, Caner (Author) , Döhler, Bernd (Author)
Format: Article (Journal)
Language:English
Published: 4 May 2016
In: Nephrology, dialysis, transplantation
Year: 2016, Volume: 31, Issue: 10, Pages: 1730-1738
ISSN:1460-2385
DOI:10.1093/ndt/gfw086
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/ndt/gfw086
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/ndt/article/31/10/1730/2222604
Get full text
Author Notes:Gerhard Opelz, Christian Unterrainer, Caner Süsal and Bernd Döhler
Description
Summary:AbstractBackground. Antibody induction with polyclonal rabbit-antithymocyte globulin (rATG) or an interleukin-2 receptor antagonist (IL−2RA) is widely used in
Item Description:Gesehen am 07.07.2020
Physical Description:Online Resource
ISSN:1460-2385
DOI:10.1093/ndt/gfw086